ACON Aclarion
- 0.3248
- +0.0123+3.94%
- 0.3010
- -0.0238-7.33%
Aclarion News
Maxim Group Maintains Aclarion(ACON.US) With Buy Rating, Announces Target Price $1.5
Maxim Group analyst Anthony Vendetti maintains $Aclarion(ACON.US)$ with a buy rating, and sets the target price at $1.5.According to TipRanks data, the analyst has a success rate of 31.7% and a total
Analysts Are Bullish on Top Healthcare Stocks: Calliditas Therapeutics (CALT), Aclarion, Inc. (ACON)
Aclarion (ACON.US): The 2024 Q1 financial report achieved revenue of $101,100, previous value of $254,700; earnings per share was -0.44 US dollars, previous value of -2.40 US dollars.
Aclarion (ACON.US): The 2024 Q1 financial report achieved revenue of $101,100, previous value of $254,700; earnings per share was -0.44 US dollars, previous value of -2.40 US dollars.
10-Q: Quarterly report
Aclarion, Inc. Secures Funds by Expanding Share Count
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) rose sharply in today's pre-market trading the company posted upbeat results for its first quarter.Google parent Alphabet said its first-quarter re
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersTevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday's pre-market session. The company's market cap stands at $245.2 million. Cryo-Cell International (AMEX:CCEL) shares i
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersAclarion (NASDAQ:ACON) shares moved upwards by 66.7% to $0.48 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million. Processa Pharma (NASDAQ:PCSA) s
Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary rehabilitation Norway is a single-payer national health insurance syst
On April 8, Aclarion Inc Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
On April 8, Aclarion Inc Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
12 Health Care Stocks Moving In Monday's After-Market Session
GainersOpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. The market value of their outstanding shares is at $7.4 million. Galecto (NASDAQ:GLTO) shares in
Aclarion Has Received A Notice Of Allowance For Its U.S. Patent Application 18/190,723 Titled "Magnetic Resonance Spectroscopy Pulse Sequence, Acquisition, And Processing System And Method (For Diagnosing Pain)".
Aclarion Has Received A Notice Of Allowance For Its U.S. Patent Application 18/190,723 Titled "Magnetic Resonance Spectroscopy Pulse Sequence, Acquisition, And Processing System And Method (For Diagno
12 Health Care Stocks Moving In Friday's After-Market Session
GainersCue Health (NASDAQ:HLTH) shares increased by 12.1% to $0.22 during Friday's after-market session. The company's market cap stands at $34.8 million. As per the press release, Q4 earnings came ou
Aclarion Has Received A Decision To Grant European Patent Number EP3928695 Titled "Magnetic Resonance Spectroscopy Pulse Sequence, Acquisition, And Processing System And Method (For Diagnosing Pain)"
Aclarion Has Received A Decision To Grant European Patent Number EP3928695 Titled "Magnetic Resonance Spectroscopy Pulse Sequence, Acquisition, And Processing System And Method (For Diagnosing Pain)"
Aclarion, Inc. (ACON) Gets a Buy From Maxim Group
Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs
Confirms predictive value of Nociscan for identifying painful discs. Nociscan demonstrated a sensitivity of 100% and a specificity of 80% compared to provocative discography (PD), sugges
Aclarion Announces Closing of $3.0 Million Public Offering
BROOMFIELD, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW) , a healthcare technology co
Top Midday Decliners
Intuitive Machines (LUNR) said Monday in a post on X, formerly known as Twitter, its Odysseus moon lander apparently pitched over while landing at the Malapert A site Friday. Shares sank 36% as intrad
Crude Oil Gains 1%; US New Home Sales Increase In January
U.S. stocks traded mixed midway through trading, with the S&P 500 edging lower on Monday. The Dow traded up 0.03% to 39,143.57 while the NASDAQ rose 0.10% to 16,013.16. The S&P 500 also rose, gaining,
Analysis
Price Target
No Data
